The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we go off and if we're again if we're lucky we get beautiful big fat effector B cells that turn into plasma cells they hang out in bone marrow they are just sitting there primed and ready and if you see this infection again it's not even going to be a blip on the radar because the antibodies are right there right away to neutralize
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.